Mifepristone alters expression of endometrial steroid receptors and their cofactors in new users of medroxyprogesterone acetate

Fertility and Sterility

Volumn 87, Issue 1, 2007, Pages 8-23

  Jain, John K ^a   Li, Aimin ^a   Yang, Wangrong ^a   Minoo, Parviz ^a   Felix, Juan C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Breakthrough bleeding; cofactor; hormone receptor; mifepristone; proliferation

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; MIFEPRISTONE; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; PROTEIN; RETINOIC ACID RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; THYROID HORMONE RECEPTOR;

ARTICLE; CELL PROLIFERATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; ENDOMETRIUM ATROPHY; ENDOMETRIUM BIOPSY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE;

CONTRACEPTIVES, ORAL, SYNTHETIC; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ENDOMETRIUM; FEMALE; GENE EXPRESSION; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIFEPRISTONE; PLACEBO EFFECT; PROTEIN ISOFORMS; RECEPTORS, STEROID;

EID: 33845757985     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.05.076     Document Type: Article

References (54)

1. Belsey E.M. The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use. Contraception 38 (1988) 207-225
2. Wang G., Zheng S., and Fan Z. [The changes of sex steroid receptors and morphology in Norplant treated endometrium]. Zhonghua Fu Chan Ke Za Zhi 33 (1998) 493-497
3. Zhu P., Liu X., Luo H., Gu Z., Cheng J., Xu R., et al. The effect of a levonorgestrel-releasing intrauterine device on human endometrial oestrogen and progesterone receptors after one year of use. Hum Reprod 14 (1999) 970-975
4. Glasier A.F., Wang H., Davie J.E., Kelly R.W., and Critchley H.O. Administration of an antiprogesterone up-regulates estrogen receptors in the endometrium of women using Norplant: a pilot study. Fertil Steril 77 (2002) 366-372
5. Cheng L., Zhu H., Wang A., Ren F., Chen J., and Glasier A. Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel. Hum Reprod 15 (2000) 1969-1972
6. Massai M.R., Pavez M., Fuentealba B., Croxatto H.B., and d'Arcangues C. Effect of intermittent treatment with mifepristone on bleeding patterns in Norplant implant users. Contraception 70 (2004) 47-54
7. Jain J.K., Nicosia A.F., Nucatola D.L., Lu J.J., Kuo J., and Felix J.C. Mifepristone for the prevention of breakthrough bleeding in new starters of depo-medroxyprogesterone acetate. Steroids 68 (2003) 1115-1119
8. Cadepond F., Ulmann A., and Baulieu E.E. RU486 (mifepristone): mechanisms of action and clinical uses. Annu Rev Med 48 (1997) 129-156
9. Slayden O.D., and Brenner R.M. Hormonal regulation and localization of estrogen, progestin and androgen receptors in the endometrium of nonhuman primates: effects of progesterone receptor antagonists. Arch Histol Cytol 67 (2004) 393-409
10. Hodgen G.D., van Uem J.F., Chillik C.F., Danforth D.R., Wolf J.P., Neulen J., et al. Non-competitive anti-oestrogenic activity of progesterone antagonists in primate models. Hum Reprod 9 suppl 1 (1994) 77-81
11. Zelinski-Wooten M.B., Slayden O.D., Chwalisz K., Hess D.L., Brenner R.M., and Stouffer R.L. Chronic treatment of female rhesus monkeys with low doses of the antiprogestin ZK 137 316: establishment of a regimen that permits normal menstrual cyclicity. Hum Reprod 13 (1998) 259-267
12. Cameron S.T., Critchley H.O., Thong K.J., Buckley C.H., Williams A.R., and Baird D.T. Effects of daily low dose mifepristone on endometrial maturation and proliferation. Hum Reprod 11 (1996) 2518-2526
13. Croxatto H.B., Kovacs L., Massai R., Resch B.A., Fuentealba B., Salvatierra A.M., et al. Effects of long-term low-dose mifepristone on reproductive function in women. Hum Reprod 13 (1998) 793-798
14. Li A., Felix J.C., Minoo P., Amezcua C.A., and Jain J.K. Effect of mifepristone on proliferation and apoptosis of Ishikawa endometrial adenocarcinoma cells. Fertil Steril 84 (2005) 202-211
15. Slayden O.D., Nayak N.R., Burton K.A., Chwalisz K., Cameron S.T., Critchley H.O., et al. Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium. J Clin Endocrinol Metab 86 (2001) 2668-2679
16. Brenner R.M., Slayden O.D., Nayak N.R., Baird D.T., and Critchley H.O. A role for the androgen receptor in the endometrial antiproliferative effects of progesterone antagonists. Steroids 68 (2003) 1033-1039
17. Brenner R.M., Slayden O.D., and Critchley H.O. Anti-proliferative effects of progesterone antagonists in the primate endometrium: a potential role for the androgen receptor. Reproduction 124 (2002) 167-172
18. Brenner R.M., and Slayden O.D. Progesterone receptor antagonists and the endometrial antiproliferative effect. Semin Reprod Med 23 (2005) 74-81
19. Slayden O.D., and Brenner R.M. Flutamide counteracts the antiproliferative effects of antiprogestins in the primate endometrium. J Clin Endocrinol Metab 88 (2003) 946-949
20. McKenna N.J., Lanz R.B., and O'Malley B.W. Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20 (1999) 321-344
21. Rachez C., and Freedman L.P. Mediator complexes and transcription. Curr Opin Cell Biol 13 (2001) 274-280
22. Shiozawa T., Shih H.C., Miyamoto T., Feng Y.Z., Uchikawa J., Itoh K., et al. Cyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium. J Clin Endocrinol Metab 88 (2003) 871-878
23. Wieser F., Schneeberger C., Hudelist G., Singer C., Kurz C., Nagele F., et al. Endometrial nuclear receptor co-factors SRC-1 and N-CoR are increased in human endometrium during menstruation. Mol Hum Reprod 8 (2002) 644-650
24. Uchikawa J., Shiozawa T., Shih H.C., Miyamoto T., Feng Y.Z., Kashima H., et al. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression. Cancer 98 (2003) 2207-2213
25. Freedman L.P. Increasing the complexity of coactivation in nuclear receptor signaling. Cell 97 (1999) 5-8
26. Huang H.J., Norris J.D., and McDonnell D.P. Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists. Mol Endocrinol 16 (2002) 1778-1792
27. Noyes R.W., Hertig A.T., and Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol 122 (1975) 262-263
28. Jain J.K., Li A., Minoo P., Nucatola D.L., and Felix J.C. The effect of nonoxynol-9 on human endometrium. Contraception 71 (2005) 137-142
29. Jain J.K., Li A., Nucatola D.L., Minoo P., and Felix J.C. Nonoxynol-9 induces apoptosis of endometrial explants by both caspase-dependent and -independent apoptotic pathways. Biol Reprod 73 (2005) 382-388
30. Li A., Felix J.C., Hao J., Minoo P., and Jain J.K. Menstrual-like breakdown and apoptosis in human endometrial explants. Hum Reprod 20 (2005) 1709-1719
31. Gerdes J., Lemke H., Baisch H., Wacker H.H., Schwab U., and Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133 (1984) 1710-1715
32. Nap A.W., Dunselman G.A., de Goeij A.F., Evers J.L., and Groothuis P.G. Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model. Hum Reprod 19 (2004) 2180-2187
33. Greb R.R., Kiesel L., Selbmann A.K., Wehrmann M., Hodgen G.D., Goodman A.L., et al. Disparate actions of mifepristone (RU 486) on glands and stroma in the primate endometrium. Hum Reprod 14 (1999) 198-206
34. Slayden O.D., Hirst J.J., and Brenner R.M. Estrogen action in the reproductive tract of rhesus monkeys during antiprogestin treatment. Endocrinology 132 (1993) 1845-1856
35. Slayden O.D., Zelinski-Wooten M.B., Stouffer R.L., and Brenner R.M. Radioligand binding assay of progesterone receptors in the primate corpus luteum after in vivo treatment with the 3 beta-hydroxysteroid dehydrogenase inhibitor, trilostane. J Clin Endocrinol Metab 79 (1994) 620-626
36. Neulen J., Williams R.F., and Hodgen G.D. RU 486 (mifepristone): induction of dose dependent elevations of estradiol receptor in endometrium from ovariectomized monkeys. J Clin Endocrinol Metab 71 (1990) 1074-1075
37. Murphy A.A., Kettel L.M., Morales A.J., Roberts V., Parmley T., and Yen S.S. Endometrial effects of long-term low-dose administration of RU486. Fertil Steril 63 (1995) 761-766
38. Slayden O.D., Zelinski-Wooten M.B., Chwalisz K., Stouffer R.L., and Brenner R.M. Chronic treatment of cycling rhesus monkeys with low doses of the antiprogestin ZK 137 316: morphometric assessment of the uterus and oviduct. Hum Reprod 13 (1998) 269-277
39. Murphy A.A., Kettel L.M., Morales A.J., Roberts V.J., and Yen S.S. Regression of uterine leiomyomata in response to the antiprogesterone RU 486. J Clin Endocrinol Metab 76 (1993) 513-517
40. Danielsson K.G., Swahn M.L., Westlund P., Johannisson E., Seppala M., and Bygdeman M. Effect of low daily doses of mifepristone on ovarian function and endometrial development. Hum Reprod 12 (1997) 124-131
41. Gopalkrishnan K., Katkam R.R., Sachdeva G., Kholkute S.D., Padwal V., and Puri C.P. Effects of an antiprogestin onapristone on the endometrium of bonnet monkeys: morphometric and ultrastructural studies. Biol Reprod 68 (2003) 1959-1967
42. Narvekar N., Cameron S., Critchley H.O., Lin S., Cheng L., and Baird D.T. Low-dose mifepristone inhibits endometrial proliferation and up-regulates androgen receptor. J Clin Endocrinol Metab 89 (2004) 2491-2497
43. Dahmoun M., Boman K., Cajander S., Westin P., and Backstrom T. Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of the secretory phase. J Clin Endocrinol Metab 84 (1999) 1737-1743
44. Nisolle M., Casanas-Roux F., and Donnez J. Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis. Fertil Steril 68 (1997) 912-919
45. Garcia-Becerra R., Borja-Cacho E., Cooney A.J., Jackson K.J., Lemus A.E., Perez-Palacios G., et al. The intrinsic transcriptional estrogenic activity of a non-phenolic derivative of levonorgestrel is mediated via the estrogen receptor-alpha. J Steroid Biochem Mol Biol 82 (2002) 333-341
46. Couse J.F., Curtis S.W., Washburn T.F., Lindzey J., Golding T.S., Lubahn D.B., et al. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol Endocrinol 9 (1995) 1441-1454
47. Krege J.H., Hodgin J.B., Couse J.F., Enmark E., Warner M., Mahler J.F., et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A 95 (1998) 15677-15682
48. Wen D.X., Xu Y.F., Mais D.E., Goldman M.E., and McDonnell D.P. The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol 14 (1994) 8356-8364
49. Giangrande P.H., Pollio G., and McDonnell D.P. Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor. J Biol Chem 272 (1997) 32889-32900
50. Giangrande P.H., Kimbrel E.A., Edwards D.P., and McDonnell D.P. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol Cell Biol 20 (2000) 3102-3115
51. Mote P.A., Balleine R.L., McGowan E.M., and Clarke C.L. Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. J Clin Endocrinol Metab 84 (1999) 2963-2971
52. Sun X., Christow A., Marions L., and Gemzell-Danielsson K. Progesterone receptor isoform B in the human fallopian tube and endometrium following mifepristone. Contraception 67 (2003) 319-326
53. Tai H., Kubota N., and Kato S. Involvement of nuclear receptor coactivator SRC-1 in estrogen-dependent cell growth of MCF-7 cells. Biochem Biophys Res Commun 267 (2000) 311-316
54. Wagner B.L., Norris J.D., Knotts T.A., Weigel N.L., and McDonnell D.P. The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor. Mol Cell Biol 18 (1998) 1369-1378